Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.14 USD | +1.23% | -0.25% | -13.45% |
30/04 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
08/03 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
Business Summary
Number of employees: 56
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 01/17/01 |
Timothy Rolph
FOU | Founder | 70 | 01/17/01 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/18/01 |
William White
DFI | Director of Finance/CFO | 51 | 01/19/01 |
Chief Tech/Sci/R&D Officer | - | 01/20/01 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 01/22/01 |
Patrick Lamy
PRN | Corporate Officer/Principal | - | 01/23/01 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 01/18/01 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 01/17/01 |
Jane Henderson
BRD | Director/Board Member | 59 | 23/19/23 |
Mark Iwicki
CHM | Chairman | 57 | 01/18/01 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/18/01 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 09/20/09 |
Jonathan Young
FOU | Founder | 54 | 01/17/01 |
Judy Chou
BRD | Director/Board Member | 58 | 12/21/12 |
Graham Walmsley
BRD | Director/Board Member | 37 | 01/18/01 |
Yuan Xu
BRD | Director/Board Member | 56 | 22/21/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,151,007 | 59,000,851 ( 85.32 %) | 0 | 85.32 % |
Company contact information
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.45% | 1.38B | |
-3.30% | 102B | |
+1.32% | 96.09B | |
+2.13% | 22.28B | |
-16.89% | 21.4B | |
-8.84% | 18.14B | |
-39.98% | 17.02B | |
-14.29% | 16.09B | |
+6.12% | 13.83B | |
+32.98% | 11.97B |
- Stock Market
- Equities
- AKRO Stock
- Company Akero Therapeutics, Inc.